The oligomerization chain reaction (OCR) strategy is a recently described technique for inactivation of target proteins that function as homoassociate complexes. This novel strategy is based on the fusion of self-associating coiled-coil (CC) domain of the nuclear factor promyelocytic leukemia (PML) to target proteins. Here, we present the successful application of the OCR strategy for inactivation of the heterodimeric Cdk9/cyclin T1 complex. Cyclin T1/Cdk9 (P-TEFb) complex is a positive regulator of gene transcription, whose function is underlined by the ability to phosphorylate the carboxyl-terminal domain (CTD) of the RNA polymerase II conferring productive transcript elongation. Fusion of the CC domain to Cdk9 leads to the formation of high molecular complexes to which the endogenous cyclin T1 is recruited. The CC-Cdk9 chimera effectively inhibits HIV-1 Tat activation, whose transcription activity is exquisitely dependent upon cyclin T1/Cdk9 function. Furthermore, expression of CC-Cdk9 protein inhibits cell proliferation, as shown by colony-formation assay. Collectively, our findings add further support to the OCR strategy for functional inactivation of hetero-associated factors such as the Cdk9/cyclin T1 complex, and highlight a putative function of Cdk9 in cell growth control.
Introduction
The oligomerization protein inactivation (OCR) is a recently devised strategy to achieve functional ablation of a protein in vivo (Contegno et al. , 2002) . This strategy relies on the ability of the coiled-coil (CC) region of the nuclear factor promyelocytic leukemia (PML) to form self-associating oligomeric complexes. In acute promyelocytic leukemia (APL), the PML is fused to the retinoic acid receptor (RAR). The PML-RAR forms self-associated complexes and oligomerization is mediated by the CC domain of PML (Lin and Evans, 2000; Minucci et al., 2000 Minucci et al., , 2001 Salomoni and Pandolfi, 2000) . Since the CC domain is sufficient to induce oligomerization of the RAR protein, it has been suggested that the presence of the CC domain of PML might be used to modify the function of a target protein (Lin and Evans, 2000; Minucci et al., 2000; Contegno et al., 2002) . Indeed, fusion of CC to p53 protein leads to formation of highmolecular complexes with a consequent inhibition of the p53 function (Contegno et al., 2002) . OCR strategy would, in principle, inactivate target proteins that are able to self-associate. However, hetero-oligomeric factors, such as Cdk-cyclin complexes, may also be considered as a valid target for OCR. As a test case, we investigated the possibility that the CC of PML might be used to modify the function of Cdk9/cyclinT (P-TEFb) complex.
Cdk9 in association with cyclin T (T1 or T2) constitutes the P-TEFb complex that stimulates transcription elongation of RNAPII transcripts by phosphorylating the carboxyl-terminal domain (CTD) of RNAPII (Price, 2000 and references therein) . Hypophosphorylated RNAPII (IIa) is recruited to promoters (Conaway et al., 2000 and references therein), shortly after the CTD becomes extensively phosphorylated (IIo), primarily at Ser2 and Ser5 of the heptapeptide repeat, to overcome proximal promoter pausing and confer productive transcript elongation (Wada et al., 1998; Yamaguchi et al., 1999) . P-TEFb appears to be required for transcription of most class II genes (Majello et al., 1999; Lis et al., 2000; Price, 2000; Shim et al., 2002; Taube et al., 2002) and the human Cdk9/cyclin T1 complex is a direct cellular target of the HIV-1 activator, Tat (Mancebo et al., 1997; Zhu et al., 1997; Bieniasz et al., 1998; Garber et al., 1998; Wei et al., 1998; Zhou et al., 1998) .
Here we present evidences for effective inactivation of Cdk9/cyclin T1 activity in cell culture through OCR. We demonstrate that fusion of CC to Cdk9 triggers the formation of large molecular weight heterocomplexes, leading to a functional inactivation of the Cdk9/cyclin T1 transcription regulatory properties. Based on these findings, we propose that OCR strategy may be of general application for functional inactivation of heterocomplexes such as the Cdk/cyclin complexes.
Materials and methods

Constructs
The Flag-Cdk9 was constructed by insertion of the full-length Cdk9 cDNA (Majello et al., 1999) into the EcoRV site of p3xFlag-CMV10 vector (Clontech). To generate the Flag-CCCdk9, the PML CC cDNA region (encoding amino acids from aa200 to aa339 of the PML protein) was isolated by PCR using the PML cDNA as template, and then inserted between the EcoRI-BgIII sites of the Flag-Cdk9. The EcoRI-BamHI fragment of this plasmid (encoding the CC-Cdk9 fusion) was then inserted into the pEGFP-C1 (Clontech) vector to generate GFP-CC-Cdk9 plasmid. CC-VDR, GAL4-CycT1, G5-83HIV-Luc and GFP-Cdk9 vectors have been previously described (Majello et al., 1999; Napolitano et al., 2000 Napolitano et al., , 2002 Contegno et al., 2002) . All vectors were analysed by DNA sequencing.
Cell culture and transfections
HeLa, H1299 and CHO cells were grown in Dulbecco's modified Eagle medium supplemented with 10% FBS. For luciferase assays and GFP localization, cells were transfected in 35 mm multiwells by the liposome method using LipofectA-MINE reagent (Invitrogen, Life Technologies), as previously described (Napolitano et al., 2000 (Napolitano et al., , 2002 . For luciferase assays, 100 ng of reporter DNA and different amounts as indicated in the figure legends of each effector were transfected along with 20 ng of pRL (Renilla Luciferase) for internal transfection control (Dual Reporter Luciferase Assay, Promega). GFP analysis was carried out as recently described (Napolitano et al., 2002) . Briefly, after transfection cells were washed in 1 Â cold PBS, fixed in PFA 4% in PBS and after extensive washes (1 Â PBS), nuclei were stained with Hoechst 33258 (SIGMA). Slides were analysed by fluorescence microscopy and images were digitally processed using Adobe Photoshop Software.
Glycerol gradient and coimmunoprecipitation
Whole-cell extracts were prepared from HeLa cells transfected with Flag-Cdk9 or Flag-CC-Cdk9 as indicated. Extracts were obtained using buffer A (Nguyen et al., 2001) . As indicated, RNase A (1 mg/ml) was added and extracts were incubated at 371C for 10 min. Protein extracts were then ultracentrifuged at 40 000 r.p.m. for 16 h at 41C in SW40.1 rotor on a preformed 5-45% discontinuous glycerol gradient containing buffer A. Samples were collected in 10 fractions (1 ml each starting from the top), and the residual pellets were resuspended in buffer A. In all, 20 ml of each fraction were separated by SDS-PAGE and analysed by Western blotting using appropriate antibodies. The following antibodies were used: anti-Flag M2 monoclonal antibody peroxidase conjugate (Sigma), anticyclin T1 (sc 10750, Santa Cruz) and anti-Cdk9 (sc 8338, Santa Cruz). Coimmunoprecipitation analyses were performed using whole-cell extracts incubated with the anti-Flag-M2 monoclonal antibody attached to agarose beads (Sigma). After extensive washes, the recovered beads were resuspended in Laemmli buffer resolved on SDS-PAGE and analysed by Western blotting with anti-CycT1 antibody. For coimmunoprecipitation of 7SK snRNA, total RNA was isolated from Flag-immuno-complexes and subjected to DNase I treatment, followed by reverse transcription using antisense oligonucleotides for 7SK snRNA.
The PCR primers were: sense GGATGTGAGGC-GATCTGGCTG; antisense, TAAAGAAAGGCAGACTGC-CAC. PCR products were analysed on agarose gels. Cell fractionation into cytoplasmic and nuclear fractions was performed as described (Napolitano et al., 2002) . Equal cell volumes from nuclear and cytoplasmic fractions were analysed by Western blotting using anti-cyclin T1 (sc 10750, Santa Cruz). Binding was visualized by enhanced chemiluminescence (ECL-plus Kit, Amersham).
Colony-formation assay
HeLa and H1299 cells were transfected by calcium phosphate with the indicated expression vectors. At 48 h post-transfection, cells were counted and seeded at 20 000 cells per 10 cm culture dish, grown in medium containing G418 (500 mg/ml) for 2 weeks and then stained with Crystal Violet dye. Colonies were counted from duplicate plates and values are reported for three independent experiments.
Results
Oligomerization chain reaction
The OCR is a novel strategy based on the capacity of the CC domain of the nuclear factor PML, to induce oligomerization. It has been recently shown that the fusion of p53 with the CC domain of PML inhibits p53 activity, thus indicating that the OCR strategy could represent a valid tool for the functional inactivation of proteins that oligomerizes naturally in vivo (Contegno et al., 2002) . It has been suggested that the presence of an oligomerization induced by the CC domain of PML would lead to the formation of aberrant, nonfunctional high molecular mass complexes (Contegno et al., 2002) . Since the OCR strategy is effective on target proteins that oligomerizes naturally, we reasoned that possible targets for OCR could also be hetero-oligomers such as Cyc/Cdk complexes. In principle, the oligomerization (CC) domain of PML fused to Cdk should impose an altered oligomerization state not only of the CC-fused chimera, but also of its natural regulatory cyclin subunit, leading to functional inhibition of the complex through the formation of inactive OCR aggregates ( Figure 1 ). As a test case, we sought to inhibit the activity of the cyclinT/Cdk9 (P-TEFb) complex. PTEFb is a multiprotein complex involved in transcription regulation. Cdk9 in association with cyclin T (T1 or T2), constitutes the P-TEFb complex that stimulates transcription elongation of RNAPII transcripts by phosphorylating the CTD of RNAPII (Price, 2000 and references therein) .
A strict requirement for the chimeric Cdk9 protein would be the capacity to associate with the regulatory cyclin T partner. We fused the CC region of PML at the amino-terminal of the full-length Cdk9 to generate the Flag-CC-Cdk9, and then compared its functional activity to the isogenic Flag-Cdk9, vector. HeLa cells were transfected with the Flag-Cdk9 and the Flag-CCCdk9 vectors, respectively, and interactions with the endogenous regulative partner cyclin T1 were monitored by coimmunoprecipitation. As shown in the upper panel of Figure 2a , we found that CC-Cdk9 interacts as efficiently as Cdk9 with the endogenous cyclin T1.
It has been recently shown that almost half of the PTEFb in vivo is associated with the small nuclear 7SK
OCR-mediated inactivation of Cdk9 G Napolitano et al RNA (Nguyen et al., 2001; Yang et al., 2001) . Moreover, association of the 7SK snRNA has been shown to inhibit the activity of P-TEFb (Nguyen et al., 2001; Yang et al., 2001) . To monitor the physical association between the endogenous 7SK snRNA with the exogenously expressed CC-Cdk9, the presence of 7SK snRNA from immunoprecipitated materials was analysed by RT-PCR. We found that the CC-Cdk9 chimera, like the parental Cdk9 protein, interacts with 7SK snRNA (Figure 2a, lower panel) .
These results demonstrated that the CC-Cdk9 chimera retains the ability to associate with cyclin T1 and 7SK snRNA, despite the presence of the PML-CC extra-oligomerization domain.
To test if the fusion of Cdk9 to the CC domain of PML might induce the formation of high molecular mass complexes, we analysed the sedimentation properties of Cdk9/cyclin T1 using glycerol gradient fractionation. Cellular lysates from transiently transfected HeLa cells were ultracentrifugated on a glycerol gradient and the recovered fractions were analysed by Western blotting. Accordingly with recent findings (Nguyen et al., 2001) , the exogenous Flag-Cdk9 and the endogenous cyclin T1 cosedimented in two sets of fractions (Figure 2b ). Flag-Cdk9 and cyclin T1 in fractions 3 and 4 correspond to the active core P-TEFb and fractions 6 and 7 to the inactive P-TEFb/7SK snRNA complex (Nguyen et al., 2001) . Consistent with the presence of the PML CC oligomerization domain, the Flag-CC-Cdk9 fusion was found in fractions (8 to the pellet) corresponding to an apparent molecular weight ranging from 500 kDa to 41 MDa (Figure 2c ), while the endogenous Cdk9 was mainly found in fractions (4 and 5) corresponding to the low molecular weight complexes (Figure 2c ).
In the presence of overexpressed Flag-CC-Cdk9, the endogenous cyclin T1 displayed an aberrant sedimentation profile. Cyclin T1 was found to partly cofractionate with the chimeric CC-Cdk9 protein.
Given the capacity of CC-Cdk9 to associate with endogenous cyclin T1, we interpreted the widespread distribution of the two proteins as the result of populations of differently sized hetero-oligomeric complexes.
Transcription inactivation of P-TEFb by OCR targeting P-TEFb represents the cellular target of the viral transcription transactivator Tat (Mancebo et al., 1997; Zhu et al., 1997; Bieniasz et al., 1998; Garber et al., 1998; Wei et al., 1998; Zhou et al., 1998) . Indeed, Tat strongly activates transcription of the HIV-1 LTR promoter through the recruitment of P-TEFb on the TAR RNA structure present at the 5 0 of all the nascent viral transcripts. Since Tat-mediated activation of HIV-1 LTR promoter is strictly dependent upon cyclin T1/ Cdk9 activity, we sought to determine the functional consequences of the overexpression of CC-Cdk9 protein on HIV-1 LTR-driven gene transcription. As presented in Figure 3a , we found that Tat-mediated transactivation of the HIV-1 LTR was effectively inhibited by the overexpression of Flag-CC-Cdk9 in a dose-dependent manner. In contrast, overexpression of Cdk9 protein did not significantly alter Tat activity. As a control of the specificity of the CC-Cdk9 on Tat function, the chimera CC-VDR (Contegno et al., 2002) encoding for an unrelated transcription factor (vitamin d receptor), fused to the PLM CC domain, had no effect on Tat activity (Figure 3a) . To further substantiate the inhibitory function of CC-Cdk9, we extended our analysis using the rodent CHO cells. Tat protein is a potent activator of HIV-1 LTR transcription in primate cells, but only poorly functional in rodent cells (Alonso et al., 1992) . However. Tat-mediated activation can be rescued by enforced expression of human cyclin T1 (Bieniasz et al., 1998; Garber et al., 1998; Zhou et al., 1998) . As presented in Figure 3b , we found that Tat enhancement mediated by hCycT1 was effectively abrogated by coexpression of CC-Cdk9. These findings demonstrate that the fusion of CC with Cdk9 results in a functional inactivation of PTEFb function in the context of Tat-dependent transcription.
A large number of evidences indicate that Tat transactivation is mainly due to the recruitment of the cellular complex P-TEFb to the LTR. Accordingly, it has been previously shown that direct recruitment of cyclin T1 to a promoter template by fusion to the GAL4 DNA-binding domain, activates transcription from an HIV-1 LTR reporter bearing GAL4 sites in the absence of Tat (Majello et al., 1999 , Lis et al., 2000 : Taube et al., 2002 . We sought to determine the consequences of ectopically expressed CC-Cdk9 on P-TEFb-induced transcription in the absence of Tat. HeLa cells were transfected with the G5-83HIV-Luc reporter along with GAL4-cyclin T1 vector, in the presence of increasing amounts of Cdk9 and CC-Cdk9, respectively. As shown in Figure 3 panel c, we found that GAL4-CycT1 effectively activates transcription from the HIV-1 LTR reporter, and coexpression of either Cdk9 did not significantly affect GAL4-CycT1-mediated activation. In contrast, coexpression of CCCdk9 strongly inhibited the GAL4-cyclin T1 activation of the HIV-1 promoter.
Subcellular localization of CC-Cdk9
To further analyse the dominant-negative effect exerted by the PML CC oligomerization domain on Cdk9, we checked for proper subcellular localization of the CCCdk9. HeLa cells were transiently transfected with expression vectors for GFP-Cdk9 and GFP-CC-Cdk9 and analysed by fluorescence imaging, to check if the fusion of Cdk9 with the CC domain could alter the normal Cdk9 intracellular distribution. Accordingly with previous studies (Herrmann and Mancini, 2001; Marcello et al., 2001; Napolitano et al., 2002) , we found that GFP-Cdk9 displayed a substantial nuclear localization (Figure 4a, b) . In sharp contrast, the GFP-CCCdk9 was almost entirely localized in the cytoplasm (Figure 4c, d) . Since GFP-CC-Cdk9 behaves identically to CC-Cdk9 in all transcriptional assays tested (data not shown), it is likely that the dominant-negative effect of CC-Cdk9 is at least in part, achieved through the formation of subcellular delocalized oligomeric complexes. To address this point, the subcellular localization of the endogenous cyclin T1 was assessed by Western blotting of cellular fractionated extracts derived from cells transfected with either GFP-Cdk9 or GFP-CC-Cdk9. Western blotting with anti-cycT1 indicated that endogenous cyclinT1 was, at least in part, delocalized in the cytoplasm of cells transfected with the CC-Cdk9. In contrast, an exclusive nuclear localization was observed in the presence of GFP-Cdk9 (Figure 4  lower panel) .
Finally, as previously discussed (Contegno et al., 2002) , in principle, it is possible that the CC-based chimeras may interact with wt PML and interfere with its function. However, we found no evidence for colocalization of GFP-CC-Cdk9 in the PML nuclear bodies (Figure 4, panel d) , and the CC-Cdk9 chimera was not able to disrupt PML nuclear bodies (data not shown). , 2) , Flag-CC-Cdk9 (lanes 3, 4) and mock transfected (lanes 5, 6) were resolved on SDS-PAGE and analysed by Western blotting using anti-cyclin T1 antibody. Lower panel, total RNA was isolated from the whole-cell extracts (I) and from Flag-immunoprecipitated (IP) complexes and was subjected to RT-PCR using primers specific for 7SK snRNA. PCR products were analysed on 1% agarose gel. Panel b: HeLa cells were transfected with Flag-Cdk9 vector DNA and whole-cell extracts were fractionated by ultracentrifugation on a glycerol gradient. The distribution of Flag-Cdk9 and cyclin T1 in gradient fractions (1-10) and pellet (P) was monitored by Western blotting using the indicated antibodies. The fractions containing the small (SC) and large (LC) Cdk9/cyclin T1 complexes are indicated. Panel c: wholecell extracts from Flag-CC-Cdk9 transiently transfected cells were fractionated on a glycerol gradient. Fractions (1-10) and pellet (P) were analysed by Western blotting using specific antibodies as indicated OCR-mediated inactivation of Cdk9 G Napolitano et al
OCR-mediated inactivation of Cdk9 affects cell proliferation
Several studies suggested a putative role of P-TEFb in apoptotic and cellular differentiation programs. An antiapoptotic function has been suggested upon activation of the NF-kB pathway in TNF-a-responsive cells (Barboric et al., 2001 ) and during activation of peripheral blood lymphocytes (Foskett et al., 2001 ). More recently. P-TEFb activity has been involved in differentiation of muscle cells (Simone et al., 2002) , in cardiac hypertrophy (Sano et al., 2002) and during development of the C.elegans embryo (Shim et al., 2002) .
To evaluate the functional consequences of CC-Cdk9 expression on cell proliferation, we performed a colonyformation assay (CFA) using HeLa cells and p53À/À H1299 human cell lines. After 2 weeks of drug selection, it was evident that the number of colonies in CC-Cdk9 transfections was reduced relative to the number of colonies in control empty vector transfections. In 
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G Napolitano et al contrast, Cdk9 slightly increased the number of colonies (compared to the empty vector). Similar reduction of cell colonies after transfection with CC-Cdk9 was observed in both HeLa and H1299 cells (Figure 5a) . Furthermore, although a full-length Flag-CC-Cdk9 protein was clearly detectable by Western analysis at 36 h after transfections, an aberrant Flag-CC-Cdk9 chimera was detected on the pool of Flag-CC-Cdk9-transfected colonies after drug selection, suggesting that expression of a full-length CC-Cdk9 fusion protein is incompatible with a normal cell growth (Figure 5b) . Finally, we found that the cell growth properties of the colonies formed in the CC-Cdk9 transfections were profoundly altered; that is, the cells grew very poorly and repeated attempts to isolate clones stably expressing CC-Cdk9 were not successful, indicating that the dominant-negative effect of CCCdk9 on P-TEFb activity inhibits cell proliferation. Collectively, these findings demonstrated that constitutive expression of CC-Cdk9 caused either growth arrest or cell death.
Discussion
Cyclin-dependent kinases have emerged as key regulators of cell cycle and they have been intensely studied as potential targets for cancer therapies. However, identification of a selective inhibitor for a particular Cdk is a critical issue for the development of a potential biological tool for an innovative therapeutic approach (Senderowicz and Sausville. 2000; Sausville, 2002) . In our study, we have presented the successful application of the OCR strategy for an effective inhibition of a specific Cdk/cyclin complex (Cdk9/cyclin T1). The OCR is a recently described strategy based on the fusion of the CC domain of the nuclear factor PML, to a target protein capable of self-association. The CC domain confers to the target an extra-oligomerization domain, inducing the formation of aberrant large molecular weight complexes. OCR has been shown to be an effective strategy for the in vivo inactivation of p53 (Contegno et al., 2002) . Here we tested the function of OCR in the contest of hetero-oligomers such as Cdk/ cyclin complexes. The fusion of the CC domain to a Cdk (or to the cyclin) subunit should impose an altered structure to the complex due to the presence of the CC extraoligomerization domain (Figure 1) .
As a test case, we carried out the functional inactivation of Cdk9/cyclin T1 (P-TEFb) complex. Cdk9/cyclin T complex phosphorylates the CTD of RNAPII, allowing productive transcription elongation (Price, 2000) . Moreover, the Cdk9/cyclin T1 is the cellular cofactor of the HIV-1 transactivator Tat (Mancebo et al., 1997; Zhu et al., 1997; Bieniasz et al., 1998; Garber et al., 1998; Wei et al., 1998; Zhou et al., 1998) . Our results show that addition of the PML CC domain to the Cdk9 results in an oligomerization chain reaction that alters the functional properties of the Cdk9/cyclin T1 complex. The exogenously expressed CC-Cdk9 chimera retains the ability to associate with the endogenous regulatory partner cyclin T1. Fusion of Cdk9 with the CC domain induces the formation of aberrant large molecular weight complexes, to which the regulatory partner cyclin T1 is recruited. As a result of titration of the regulatory partner cyclin T1, a significant dominant-negative effect takes place in vivo. We found that the CC-Cdk9 effectively inhibits the Tat activity, which is specifically dependent upon the endogenous cyclin T1/Cdk9 activity Mancebo et al., 1997; Bieniasz et al., 1998; Garber et al., 1998; Wei et al., 1998; Zhou et al., 1998) . Furthermore, promoter activation mediated by direct recruitment of cyclin T1 through GAL4 DNA-binding sites was also strongly repressed by CC-Cdk9. Thus, the CC-Cdk9 chimera functions as a strong and specific inhibitor of P-TEFb activity in vivo. Unlike the predominant nuclear localization of Cdk9 (Herrmann and Mancini. 2001; Marcello et al., 2001; Napolitano et al., 2002) , the CCCdk9 fusion was mainly found in the cytoplasm compartment, indicating that the dominant-negative effect of CC-Cdk9 might be at least in part, achieved through altered subcellular localization. Since the CCp53 chimera was also delocalized into the cytoplasm (Contegno et al., 2002) , it is conceivable that the high molecular weight complexes formed by the CC-chimeras might be inherently unable to enter into the nucleus, and delocalization might represent a general feature of target proteins fused to the PML CC extra-oligomerization domain.
The effective dominant-negative function of CC-Cdk9 on P-TEFb activity has a significant impact on cell proliferation. Unlike the wt Cdk9, the CC-Cdk9 inhibits cell proliferation as tested by CFAs, suggesting that constitutive expression of CC-Cdk9 causes either growth arrest or cell death. Clearly, further work will be required to address this point, as well as uncover a potential direct mechanism of P-TEFb on cell proliferation. It is possible, if not likely, that the growth inhibition or cell death may result from a general inhibition of RNAPII transcription mediated by dominant-negative effect of CC-Cdk9 on P-TEFb activity. Flavopiridol, a potential antiproliferative agent currently being tested in clinical trials (Senderowicz and Sausville, 2000; Sausville, 2002) , specifically inhibits PTEFb activity and blocks most RNAPII transcription in vivo (Chao and Price, 2001) . It is likely that the potential of P-TEFb to affect cell proliferation is rather an indirect mechanism correlated to the global requirement for P-TEFb activity in RNAPII gene transcription (Shim et al., 2002) .
While additional studies may help determine whether Cdk9 is an effective antiproliferative target, other Cdks directly involved in cell-cycle progression, represent valid antiproliferative targets for OCR-mediated inhibition. Recently, suppression of Cdk4 has been proposed as a potential strategy to recruit cells to senescence (Zou et al., 2002) . The functional consequences of OCRmediated inactivation of Cdk4, are currently under investigation.
